-to- clear!
Clear

E2B Per Year

Year E2B
20246
20251543
Total 1549


E2B per Month

Month E2B
Feb 2025512
Mar 2025116
Apr 2025650
May 2025265
Jul 20241
Aug 20241
Sep 20241
Oct 20241
Dec 20242
Total 1549

E2B per Company

Company E2B
Glaxosmithkline809
HALEON144
SAAVPROD110
Novartis Pharma AG40
Phillips33
NOVARTIS PHARMA31
TAKEDA31
GlaxoSmithKline Export Ltd28
VIIV HEALTHCARE LIMITED27
Boehringer Ingelheim26
JNJFOC24
AstraZeneca24
Pfizer Inc23
16
Sanofi15
BAYER13
GLENMARK PHARMACEUTICALS12
CIPLA12
Surgipharm Limited11
Pfizer10
Norvatis Pharma9
CIPLA LTD8
BoehringerIngelheim7
Macleods Pharmaceuticals Ltd6
ROCHE5
Gilead Pharmaceuticals Ltd5
GlaxoSmithKlin5
JNJ4
ABBVIE4
Ethypharm4
UNIVERSAL CORPORATION LIMITED4
AZPRODSE03
Novartis3
Boehringer Ingleheim3
Surgipharm2
GILEAD2
Novartis Kenya2
GSK2
AZPROD2
GlaxoSmithKlineds2
SUN PHARMACEUTICAL INDUSTRIES LTD2
SAVPROD2
TH-VIIV HEALTHCARE LIMITED2
OPELLA2
Saarprod1
Imperial Managed Solutions East Africa Ltd1
GB-VIIV HEALTHCARE LIMITED1
B|Braun Medical Kenya Ltd1
KE-VIIV HEALTHCARE LIMITED1
Abbott GmbH1
MACLEODS PHARMA1
957430491
ACINO1
E2B/2025/1332 1
Merck Healthcare KGaA1
Glenmark Pharmaceuticals Kenya Ltd1
TORRENT1
JNFOC1
Phillips Therapeutics Ltd 1
Glenmark Pharmaceuticals Ltd1
PFIZERINC1
Bayer AG1
NJFOC1
Saaprod1
Total 1549